GME: Short Book Breaks, Options Reload — Print in Three Days

GameStop arrives at its September 8 full earnings release with the positioning landscape materially different from where it sat just 48 hours ago — and the shift is running in two contradictory directions at once.

The short book has broken sharply lower. ORTEX estimates 42 million shares short as of September 3, down 34% in a single session and off 29% on the week. That drops short interest as a percentage of the free float to 9.4% — a significant unwind from the 15%-plus range that had held for most of August and stood at 13.8% when the previous articles in this series were published. Previous reports tracked how shorts rebuilt almost immediately after the August 25 covering episode; this time the exit is larger and faster, coming just days before the full print. Borrow availability has moved with it, loosening sharply to 76% from the 43–48% range that prevailed through much of last week — more room in the lending pool, less squeeze pressure. Cost to borrow remains low at 0.78%, barely changed from where it has traded all month.

Options positioning has swung the other way. The put/call ratio closed Thursday at 0.43 — four standard deviations above its 20-day mean of 0.29, and the highest defensive reading recorded in the past 52 weeks against a floor of 0.24. Friday's earnings-preview article noted the PCR had collapsed to 0.26, stripped of hedges. That has reversed completely in one session. Traders who were lightest on downside protection at Friday's close are now the most defensively positioned since the previous week's squeeze episode. The divergence is the central tension: shorts are covering, but options buyers are simultaneously reaching for puts.

The ORTEX short score reflects the day's move — dropping to 72.6 from a cluster of 79–81 that persisted through all of last week. That score had been running near its highest readings in months, and the sudden break lower is consistent with the large covering print rather than a structural change in sentiment. Ryan Cohen's activist 13D stake, last filed September 3 at 8.3% of shares, has ticked down from the 9.3% previously disclosed — a reduction of roughly one percentage point per the filing register, though Schedule 13D disclosures are event-driven around the 5% threshold and positions can move without further filings. On the insider ledger, Cohen's January purchase of 500,000 shares at $21.60 remains the most recent discretionary open-market buy from a C-suite name; the subsequent trades from the General Counsel and CFO have all been preplanned or award-related sales. Analyst coverage remains a one-voice story — Wedbush has held an Underperform rating throughout, though its most recent note dates to mid-2025 and the $13.50 target is now well below the current $19.16 price, making it a poor real-time guide.

The September 8 print will test whether the large-scale short covering reflects genuine capitulation ahead of a cleaner-than-expected result — or merely a tactical pause before the short book is rebuilt once more on the other side of the number.